ResearcherMayo ClinicActive in the last 2 years

Yanxia Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6821-8343; OpenAlex author ID A5102816022. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Phosphorylation of USP32 by CDK5 regulates Rap1 stability and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-024-03263-2 ↗
Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. Co-author DOI 10.7150/jca.65071 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhiwang Song · 2 shared papers, 2022–2025 · strength 0.42
- Paper Phosphorylation of USP32 by CDK5 regulates Rap1 stability and therapeutic resistance in pancreatic ductal adenocarcinom… DOI 10.1038/s41388-024-03263-2 ↗
- Paper Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. DOI 10.7150/jca.65071 ↗
Zhi Fang · 1 shared paper, 2022 · strength 0.19
- Paper Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. DOI 10.7150/jca.65071 ↗
Jianping Xiong · 1 shared paper, 2022 · strength 0.19
- Paper Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. DOI 10.7150/jca.65071 ↗
Min Zhong · 1 shared paper, 2022 · strength 0.19
- Paper Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. DOI 10.7150/jca.65071 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.